BBC icon

Virtus LifeSci Biotech Clinical Trials ETF
BBC

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $7.75M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.23M
2
+$1.16M
3
+$354K
4
TRCT
Tower Research Capital (TRC)
New York
+$1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.23M
2
$1.16M
3
$354K
4
$1K